Your session is about to expire
← Back to Search
MyVoice:Rheum for Rheumatic Diseases
Study Summary
This trial will compare the feasibility and acceptability of MyVoice (an app) to a patient pamphlet among female patients ages 18-44.
- Rheumatic Diseases
- Physician-Patient Relationship
- Birth Control
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this clinical trial take into consideration individuals aged 25 or over?
"According to the study's enrollment prerequisites, those that are 18 years old or older and younger than 44 qualify for inclusion in this trial."
Is it feasible for me to enroll in this research effort?
"This medical study is seeking 50 volunteers aged 18 to 44 with a rheumatic disorder. Eligible participants must have at least one of four conditions certified by a specialist in arthritis: Rheumatoid arthritis (RA), Systemic Sclerosis (SSc), Myositis, and Systemic Lupus Erythematosus (SLE). Additionally, individuals should be fluent in English as no Spanish-language version exists yet; they will also require access to either a mobile phone, laptop or tablet."
Is the research team actively seeking new participants for this experiment?
"Clinicaltrials.gov demonstrates that this medical trial is currently enlisting participants, as it has been ongoing since July 29th 2021 and was recently modified on September 7th 2022."
What is the capacity of participants for this experiment?
"Affirmative. Clinicaltrials.gov has confirmed that this trial is currently open for recruitment, having been first posted on July 29th 2021 and updated as recently as September 7th 2022. This research programme seeks to enrol 50 individuals across 2 sites."
Share this study with friends
Copy Link
Messenger